These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Juxtamedullary preglomerular vascular injury precedes glomerular and tubulointerstitial injuries during the development of hypertension. Kono Y; Horii T; Nishiyama A J Hypertens; 2013 Jan; 31(1):42-3. PubMed ID: 23221929 [No Abstract] [Full Text] [Related]
45. Renal artery stenosis-when to screen, what to stent? Jennings CG; Houston JG; Severn A; Bell S; Mackenzie IS; Macdonald TM Curr Atheroscler Rep; 2014 Jun; 16(6):416. PubMed ID: 24743868 [TBL] [Abstract][Full Text] [Related]
46. Diffusion-weighted imaging and apparent diffusion coefficient values versus contrast-enhanced MR imaging in the identification and characterisation of acute pyelonephritis. Faletti R; Cassinis MC; Fonio P; Grasso A; Battisti G; Bergamasco L; Gandini G Eur Radiol; 2013 Dec; 23(12):3501-8. PubMed ID: 23887662 [TBL] [Abstract][Full Text] [Related]
47. Captopril-enhanced renal scintigraphy in the diagnosis of pediatric hypertension. Reusz GS; Kis E; Cseprekál O; Szabó AJ; Kis E Pediatr Nephrol; 2010 Feb; 25(2):185-9. PubMed ID: 19841947 [TBL] [Abstract][Full Text] [Related]
48. Blood oxygen level-dependent and perfusion magnetic resonance imaging: detecting differences in oxygen bioavailability and blood flow in transplanted kidneys. Sadowski EA; Djamali A; Wentland AL; Muehrer R; Becker BN; Grist TM; Fain SB Magn Reson Imaging; 2010 Jan; 28(1):56-64. PubMed ID: 19577402 [TBL] [Abstract][Full Text] [Related]
49. A comparison of low-dose and normal-dose gadobutrol in MR renography and renal angiography. Bayrak IK; Ozmen Z; Nural MS; Danaci M; Diren B Korean J Radiol; 2008; 9(3):250-7. PubMed ID: 18525228 [TBL] [Abstract][Full Text] [Related]
50. Renovascular hypertension in 2007: where are we now? Textor SC Curr Cardiol Rep; 2007 Nov; 9(6):453-61. PubMed ID: 17999870 [TBL] [Abstract][Full Text] [Related]
54. Motion of the distal renal artery during three-dimensional contrast-enhanced breath-hold MRA. Vasbinder GB; Maki JH; Nijenhuis RJ; Leiner T; Wilson GJ; Kessels AG; Lemaire EE; Kaandorp DW; Ho KY; van Engelshoven JM J Magn Reson Imaging; 2002 Dec; 16(6):685-96. PubMed ID: 12451582 [TBL] [Abstract][Full Text] [Related]
55. Dynamic MRI contrast enhancement of renal cortex: a functional assessment of renovascular disease in patients with renal artery stenosis. Gandy SJ; Sudarshan TA; Sheppard DG; Allan LC; McLeay TB; Houston JG J Magn Reson Imaging; 2003 Oct; 18(4):461-6. PubMed ID: 14508783 [TBL] [Abstract][Full Text] [Related]
56. [Diagnosis of renal artery stenosis with magnetic resonance angiography and stenosis quantification]. Marchand B; Hernandez-Hoyos M; Orkisz M; Douek P J Mal Vasc; 2000 Dec; 25(5):312-320. PubMed ID: 11148391 [TBL] [Abstract][Full Text] [Related]
57. Angiotensin-converting enzyme inhibitor-enhanced phase-contrast MR imaging to measure renal artery velocity waveforms in patients with suspected renovascular hypertension. Lee VS; Rofsky NM; Ton AT; Johnson G; Krinsky GA; Weinreb JC AJR Am J Roentgenol; 2000 Feb; 174(2):499-508. PubMed ID: 10658731 [TBL] [Abstract][Full Text] [Related]